The approval of perpetual futures contracts in the US may expose traders to unforeseen tax and regulatory uncertainty, as the classification of these contracts as either swaps or futures remains unresolved, according to CME Group Chairman and CEO Terry Duffy. In an interview, Duffy emphasized the ambiguity surrounding the tax implications of these contracts, stating that 'there's a consequence that nobody's talking about' and that 'there's ambiguity right there, from a tax perspective, for all US participants now.' The issue stems from the legal distinction between futures and swaps, with Duffy arguing that perpetual futures should be classified as swaps due to the periodic funding payments exchanged between long and short positions. This classification could significantly impact the tax treatment of these contracts, as gains and losses from swaps are subject to ordinary taxation, whereas those from futures are treated as 60% long-term and 40% short-term capital gains under Section 1256 of the US tax code.
However, legal experts caution that the issue is complex, and the definition of swaps is broad, leaving room for interpretation. The outcome of the ongoing legal battle between CME and the Commodity Futures Trading Commission (CFTC) over the approval of perpetual futures contracts in the US could have far-reaching implications for the tax treatment of these contracts, and market participants may face uncertainty in reporting their trades to the IRS.